Remdesivir for the treatment of COVID – final report - Beigel, J H; Tomashek, K M; Dodd, L E; Mehta, A K; Zingman, B S; Kalil, A C; Hohmann, E; Chu, H Y; Luetkemeyer, A; Kline, S; Lopez de Castilla, D; Finberg, R W; Dierberg, K; Tapson, V; Hsieh, L; Patterson, T F; Paredes, R; Sweeney, D A; Short, W R; Touloumi, G; Lye, D C; Ohmagari, N; Oh, M D; Ruiz-Palacios, G M; Benfield, T; Fätkenheuer, G; Kortepeter, M G; Atmar, R L; Creech, C B; Lundgren, J; Babiker, A G; Pett, S; Neaton, J D; Burgess, T H; Bonnett, T; Green, M; Makowski, M; Osinusi, A; Nayak, S; Lane, H C; ACTT-1 Study Group Members (N Engl J Med, 2020)